Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validating the miR Scientific Sentinel™ Platform (Sentinel PCC4 Assay) in Men Undergoing Core Needle Biopsy Due to Suspicion of Prostate Cancer for Distinguishing Between no Cancer, Low-, Intermediate- and High-Risk Prostate Cancer

NCT04100811 is registered in ClinicalTrials.gov with miR Scientific LLC as lead sponsor.

NCT NCT04100811
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04100811 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validating the miR Scientific Sentinel™ Platform (Sentinel PCC4 Assay) in Men Undergoing Core Needle Biopsy Due to Suspicion of Prostate Cancer for Distinguishing Between no Cancer, Low-, Intermediate- and High-Risk Prostate Cancer
Lead sponsor
miR Scientific LLC
Phase
Observational
Overall status
Unknown status
Start date
December 1, 2019
Completion date
December 31, 2024
Enrollment
2,019 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer